Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 2361-2380 of 3,170 trials

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

NCT00782626

The purpose of this research study is to learn if the study drug RAD001 can shrink or slow the growth of low-grade gliomas. Additionally, the safety of RAD001 will be studied. RAD001 is a drug that may act directly on tumor cells by inhibiting tumor cell growth and proliferation.

GliomaLow-grade GliomaAstrocytoma

Dana-Farber Cancer Institute23 participantsStarted Jun 2009

Phoenix, Arizona, United States • Denver, Colorado, United States • Gainesville, Florida, United States +7 more locations

COMPLETEDPhase 2< 1 mile

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

NCT02254408

The primary objective of this study is to evaluate the effect of presatovir on respiratory syncytial virus (RSV) viral load in autologous or allogeneic hematopoietic cell transplant (HCT) recipients with an acute RSV upper respiratory tract infection (URTI), the effect of presatovir on development of lower respiratory tract complication, being free of any supplemental oxygen progression to respiratory failure, and pharmacokinetics (PK), safety, and tolerability of presatovir.

Respiratory Syncytial Virus

Gilead Sciences189 participantsStarted Jan 2015

Phoenix, Arizona, United States • Duarte, California, United States • Los Angeles, California, United States +65 more locations

Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Rheumatoid Arthritis Trials in Other Cities

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH

TARGET Intracranial Aneurysm Coiling Registry

Open Label Extension for Patients Coming From the Dosing Flexibility Study in Patients With Rheumatoid Arthritis (RA)

Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Participants With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis

A Comparison of Two Assessment Tools in Predicting Treatment Success of Cimzia in Rheumatoid Arthritis Subjects

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Enhancing Equitable and Effective (E-3) Post Traumatic Stress Disorder (PTSD) Disability Assessment

Dabrafenib in Treating Patients With Solid Tumors and Kidney or Liver Dysfunction

Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors

Pilot Study of X-82 in Patients With Wet AMD

A Two-Arm Study Evaluation H.P. Acthar Injection Gel in Treatment of Chronic Migraines

Long-Term Effects of Treatment in Patients Previously Treated for Childhood Hodgkin's Lymphoma

Transfusion Requirements in Cardiac Surgery III

Other Conditions in Phoenix